Literature DB >> 29423663

Submicron Protein Particle Characterization using Resistive Pulse Sensing and Conventional Light Scattering Based Approaches.

Gregory V Barnett1, Julia M Perhacs1, Tapan K Das1, Sambit R Kar2.   

Abstract

PURPOSE: Characterizing submicron protein particles (approximately 0.1-1μm) is challenging due to a limited number of suitable instruments capable of monitoring a relatively large continuum of particle size and concentration. In this work, we report for the first time the characterization of submicron protein particles using the high size resolution technique of resistive pulse sensing (RPS).
METHODS: Resistive pulse sensing, dynamic light scattering and size-exclusion chromatography with in-line multi-angle light scattering (SEC-MALS) are performed on protein and placebo formulations, polystyrene size standards, placebo formulations spiked with silicone oil, and protein formulations stressed via freeze-thaw cycling, thermal incubation, and acid treatment.
RESULTS: A method is developed for monitoring submicron protein particles using RPS. The suitable particle concentration range for RPS is found to be approximately 4 × 107-1 × 1011 particles/mL using polystyrene size standards. Particle size distributions by RPS are consistent with hydrodynamic diameter distributions from batch DLS and to radius of gyration profiles from SEC-MALS. RPS particle size distributions provide an estimate of particle counts and better size resolution compared to light scattering.
CONCLUSION: RPS is applicable for characterizing submicron particles in protein formulations with a high degree of size polydispersity. Data on submicron particle distributions provide insights into particles formation under different stresses encountered during biologics drug development.

Entities:  

Keywords:  light scattering; protein particle; resistive pulse sensing; submicron; subvisible

Mesh:

Substances:

Year:  2018        PMID: 29423663     DOI: 10.1007/s11095-017-2306-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Factors Governing the Precision of Subvisible Particle Measurement Methods - A Case Study with a Low-Concentration Therapeutic Protein Product in a Prefilled Syringe.

Authors:  Anacelia Ríos Quiroz; Jens Lamerz; Thierry Da Cunha; Adeline Boillon; Michael Adler; Christof Finkler; Joerg Huwyler; Roland Schmidt; Hanns-Christian Mahler; Atanas V Koulov
Journal:  Pharm Res       Date:  2015-10-16       Impact factor: 4.200

2.  Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies.

Authors:  Daisuke Ejima; Kouhei Tsumoto; Harumi Fukada; Ryosuke Yumioka; Kazuo Nagase; Tsutomu Arakawa; John S Philo
Journal:  Proteins       Date:  2007-03-01

3.  Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products.

Authors:  John F Carpenter; Theodore W Randolph; Wim Jiskoot; Daan J A Crommelin; C Russell Middaugh; Gerhard Winter
Journal:  J Pharm Sci       Date:  2010-05       Impact factor: 3.534

4.  Classification and characterization of therapeutic antibody aggregates.

Authors:  Marisa K Joubert; Quanzhou Luo; Yasser Nashed-Samuel; Jette Wypych; Linda O Narhi
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

5.  A high-throughput label-free nanoparticle analyser.

Authors:  Jean-Luc Fraikin; Tambet Teesalu; Christopher M McKenney; Erkki Ruoslahti; Andrew N Cleland
Journal:  Nat Nanotechnol       Date:  2011-03-06       Impact factor: 39.213

6.  Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics.

Authors:  Maryam Ahmadi; Christine J Bryson; Edward A Cloake; Katie Welch; Vasco Filipe; Stefan Romeijn; Andrea Hawe; Wim Jiskoot; Matthew P Baker; Mark H Fogg
Journal:  Pharm Res       Date:  2015-04       Impact factor: 4.200

7.  Nanoparticulate Impurities in Pharmaceutical-Grade Sugars and their Interference with Light Scattering-Based Analysis of Protein Formulations.

Authors:  Daniel Weinbuch; Jason K Cheung; Jurgen Ketelaars; Vasco Filipe; Andrea Hawe; John den Engelsman; Wim Jiskoot
Journal:  Pharm Res       Date:  2015-01-30       Impact factor: 4.200

8.  Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses.

Authors:  Marisa K Joubert; Martha Hokom; Catherine Eakin; Lei Zhou; Meghana Deshpande; Matthew P Baker; Theresa J Goletz; Bruce A Kerwin; Naren Chirmule; Linda O Narhi; Vibha Jawa
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

9.  Aggregation of biopharmaceuticals in human plasma and human serum: implications for drug research and development.

Authors:  Tudor Arvinte; Caroline Palais; Erin Green-Trexler; Sonia Gregory; Henryk Mach; Chakravarthy Narasimhan; Mohammed Shameem
Journal:  MAbs       Date:  2013-04-09       Impact factor: 5.857

Review 10.  Quantification of Virus Particles Using Nanopore-Based Resistive-Pulse Sensing Techniques.

Authors:  Lu Yang; Takatoki Yamamoto
Journal:  Front Microbiol       Date:  2016-09-22       Impact factor: 5.640

View more
  1 in total

1.  Detection and phenotyping of extracellular vesicles by size exclusion chromatography coupled with on-line fluorescence detection.

Authors:  Diána Kitka; Judith Mihály; Jean-Luc Fraikin; Tamás Beke-Somfai; Zoltán Varga
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.